Abstract
Background
Locoregional therapy treatments for hepatic adenoma (HA) are typically limited to selective hepatic arterial embolization (HAE) to control acute hemorrhage. This systematic review sought to report the utilization of HAE and ablation for non-emergent treatment of HA.
Methods
A PubMed query identified studies reporting ablation or embolization for HA patients. Abstracts were screened to exclude studies with only patients managed for acute hemorrhage. Outcomes of interest included rate of success, complications, and repeat procedures.
Results
Of 209 initial search results, 33 full-text publications were reviewed, and 10 were selected after applying the exclusion criteria. All were published from 2005 to 2016. A total of 105 patients were included, of which 66 patients with 138 adenomas underwent elective locoregional therapy treatment. The mean size of treated adenomas was 2.9 (range 0.8–8.3) cm. HAE was utilized in 25 patients with 58 adenomas, whereas 35 patients with 68 adenomas underwent radiofrequency ablation. Six patients with 12 adenomas received microwave ablation. Most patients were female (89/105), and adenomas were associated with oral contraceptive use or hormonal therapies in 49 of 105 patients. Success was reported in 115 of 138 first-time procedures, and repeat procedures were needed after 18 of 138. Mean follow-up time was 36.4 months, with two complications.
Conclusions
Reports of elective locoregional therapy for the treatment of HA are limited to case reports and small institutional series. In the select patients treated, outcomes are acceptable, with low rates of repeat procedures or complications. This systematic review warrants further discussion and broader consideration for the treatment of HA.
Similar content being viewed by others
References
Thomeer MG, Broker M, Verheij J, et al. Hepatocellular adenoma: when and how to treat? Update of current evidence. Ther Adv Gastroenterol. 2016;9(6):898–912.
Chiche L, David A, Adam R, et al. Liver transplantation for adenomatosis: European experience. Liver Transplant. 2016;22(4):516–26.
Cho SW, Marsh JW, Steel J, et al. Surgical management of hepatocellular adenoma: take it or leave it? Ann Surg Oncol. 2008;15(10):2795–803.
Nasser F, Affonso BB, Galastri FL, Odisio BC, Garcia RG. Minimally invasive treatment of hepatic adenoma in special cases. Einstein (Sao Paulo, Brazil). 2013;11(4):524–7.
Erdogan D, van Delden OM, Busch OR, Gouma DJ, van Gulik TM. Selective transcatheter arterial embolization for treatment of bleeding complications or reduction of tumor mass of hepatocellular adenomas. Cardiovasc Interv Radiol. 2007;30(6):1252–8.
Marini P, Vilgrain V, Belghiti J. Management of spontaneous rupture of liver tumours. Digestive Surg. 2002;19(2):109–13.
Baldwin K, Katz SC, Rubin A, Somasundar P. Bipolar radiofrequency ablation of liver tumors: technical experience and interval follow-up in 22 patients with 33 ablations. J Surg Oncol. 2012;106(7):905–10.
Rhim H, Lim HK, Kim YS, Choi D. Percutaneous radiofrequency ablation of hepatocellular adenoma: initial experience in 10 patients. J Gastroenterol Hepatol. 2008;23(8 Pt 2):e422–7.
Yi B, Somasundar P, Espat NJ. Novel laparoscopic bipolar radiofrequency energy technology for expedited hepatic tumour ablation. HPB. 2009;11(2):135–9.
Ahn SY, Park SY, Kweon YO, Tak WY, Bae HI, Cho SH. Successful treatment of multiple hepatocellular adenomas with percutaneous radiofrequency ablation. World J Gastroenterol. 2013;19(42):7480–6.
Rocourt DV, Shiels WE, Hammond S, Besner GE. Contemporary management of benign hepatic adenoma using percutaneous radiofrequency ablation. J Pediatr Surg. 2006;41(6):1149–52.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006–12.
Atwell TD, Brandhagen DJ, Charboneau JW, Nagorney DM, Callstrom MR, Farrell MA. Successful treatment of hepatocellular adenoma with percutaneous radiofrequency ablation. AJR Am J Roentgenol. 2005;184(3):828–31.
Fujita S, Kushihata F, Herrmann GE, et al. Combined hepatic resection and radiofrequency ablation for multiple hepatic adenomas. J Gastroenterol Hepatol. 2006;21(8):1351–4.
Kobayashi S, Sakaguchi H, Takatsuka M, et al. Two cases of hepatocellular adenomatosis treated with transcatheter arterial embolization. Hepatol Int 2009;3(2):416–20.
Deodhar A, Brody LA, Covey AM, Brown KT, Getrajdman GI. Bland embolization in the treatment of hepatic adenomas: preliminary experience. J Vasc Interv Radiol. 2011;22(6):795–9; quiz 800.
van Vledder MG, van Aalten SM, Terkivatan T, de Man RA, Leertouwer T, Ijzermans JN. Safety and efficacy of radiofrequency ablation for hepatocellular adenoma. J Vasc Interv Radiol. 2011;22(6):787–93.
Karkar AM, Tang LH, Kashikar ND, et al. Management of hepatocellular adenoma: comparison of resection, embolization and observation. HPB. 2013;15(3):235–43.
Smolock AR, Cristescu MM, Potretzke TA, et al. Microwave ablation for the treatment of hepatic adenomas. J Vasc Interv Radiol. 2016;27(2):244–9.
Dokmak S, Paradis V, Vilgrain V, et al. A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology. 2009;137(5):1698–705.
Darnis B, Rode A, Mohkam K, Ducerf C, Mabrut JY. Management of bleeding liver tumors. J Visc Surg. 2014;151(5):365–75.
Huurman VA, Schaapherder AF. Management of ruptured hepatocellular adenoma. Digest Surg. 2010;27(1):56–60.
Stoot JH, van der Linden E, Terpstra OT, Schaapherder AF. Life-saving therapy for haemorrhaging liver adenomas using selective arterial embolization. Br J Surg. 2007;94(10):1249–53.
van Aalten SM, Terkivatan T, van der Linden E, Verheij J, de Man RA, Ijzermans JN. Management of liver adenomatosis by radiofrequency ablation. Digest Surg. 2011;28(3):173–7.
Author information
Authors and Affiliations
Corresponding author
Appendix 1
Appendix 1
PubMed search query: (“adenoma”[All Fields] AND (“hepatic”[All Fields] OR “liver”[All Fields] OR “hepatocellular”[All Fields] OR “hepatobiliary”[All Fields])) AND (“ablation”[All Fields] OR “embolization”[All Fields] OR ((“regional”[All Fields] OR “local”[All Fields]) AND (“therapies”[All Fields] OR “therapy”[All Fields])) OR “MWA”[All Fields] OR “RFA”[All Fields] OR “IRE”[All Fields] OR “HAE”[All Fields]) AND English[lang].
Rights and permissions
About this article
Cite this article
Silva, J.P., Klooster, B., Tsai, S. et al. Elective Regional Therapy Treatment for Hepatic Adenoma. Ann Surg Oncol 26, 125–130 (2019). https://doi.org/10.1245/s10434-018-6802-1
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-018-6802-1